<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-06-16">June 16, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Søren</forename><forename type="middle">D</forename><surname>Østergaard</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Research Department P</orgName>
								<orgName type="institution">Aarhus University Hospital</orgName>
								<address>
									<settlement>Risskov</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Department of Clinical Medicine</orgName>
								<orgName type="institution">Aarhus University</orgName>
								<address>
									<settlement>Aarhus</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Shubhabrata</forename><surname>Mukherjee</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of Washington</orgName>
								<address>
									<settlement>Seattle</settlement>
									<region>Washington</region>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stephen</forename><forename type="middle">J</forename><surname>Sharp</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institute of Metabolic Science</orgName>
								<orgName type="laboratory">MRC Epidemiology Unit</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Petroula</forename><surname>Proitsi</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Basic and Clinical Neuroscience</orgName>
								<orgName type="department" key="dep2">Institute of Psychiatry, Psychology and Neuroscience</orgName>
								<orgName type="institution">King&apos;s College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Luca</forename><forename type="middle">A</forename><surname>Lotta</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institute of Metabolic Science</orgName>
								<orgName type="laboratory">MRC Epidemiology Unit</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Felix</forename><surname>Day</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institute of Metabolic Science</orgName>
								<orgName type="laboratory">MRC Epidemiology Unit</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">John</forename><forename type="middle">R B</forename><surname>Perry</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institute of Metabolic Science</orgName>
								<orgName type="laboratory">MRC Epidemiology Unit</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kevin</forename><forename type="middle">L</forename><surname>Boehme</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Biology</orgName>
								<orgName type="institution">Brigham Young University</orgName>
								<address>
									<settlement>Provo</settlement>
									<region>Utah</region>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Stefan</forename><surname>Walter</surname></persName>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Department of Epidemiology and Biostatistics</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="department" key="dep3">United States of America</orgName>
								<orgName type="institution">University of California San Francisco</orgName>
								<address>
									<settlement>San Francisco</settlement>
									<region>California</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">John</forename><forename type="middle">S</forename><surname>Kauwe</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Biology</orgName>
								<orgName type="institution">Brigham Young University</orgName>
								<address>
									<settlement>Provo</settlement>
									<region>Utah</region>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Laura</forename><forename type="middle">E</forename><surname>Gibbons</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Research Department P</orgName>
								<orgName type="institution">Aarhus University Hospital</orgName>
								<address>
									<settlement>Risskov</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of Washington</orgName>
								<address>
									<settlement>Seattle</settlement>
									<region>Washington</region>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><roleName>Alzheimer's Disease Genetics Consortium ¶ , The GERAD1 Consortium ¶ , EPIC-InterAct Consortium ¶</roleName><forename type="first">Eric</forename><forename type="middle">B</forename><surname>Larson</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of Washington</orgName>
								<address>
									<settlement>Seattle</settlement>
									<region>Washington</region>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="institution">Group Health Research Institute</orgName>
								<address>
									<settlement>Seattle</settlement>
									<region>Washington</region>
									<country>United States of America</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">John</forename><forename type="middle">F</forename><surname>Powell</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Basic and Clinical Neuroscience</orgName>
								<orgName type="department" key="dep2">Institute of Psychiatry, Psychology and Neuroscience</orgName>
								<orgName type="institution">King&apos;s College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Claudia</forename><surname>Langenberg</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institute of Metabolic Science</orgName>
								<orgName type="laboratory">MRC Epidemiology Unit</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Paul</forename><forename type="middle">K</forename><surname>Crane</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Medicine</orgName>
								<orgName type="institution">University of Washington</orgName>
								<address>
									<settlement>Seattle</settlement>
									<region>Washington</region>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">United States of America</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nicholas</forename><forename type="middle">J</forename><surname>Wareham</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institute of Metabolic Science</orgName>
								<orgName type="laboratory">MRC Epidemiology Unit</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Robert</forename><forename type="middle">A</forename><surname>Scott</surname></persName>
							<email>robert.scott@mrc-epid.cam.ac.uk</email>
							<affiliation key="aff4">
								<orgName type="department">Institute of Metabolic Science</orgName>
								<orgName type="laboratory">MRC Epidemiology Unit</orgName>
								<orgName type="institution">University of Cambridge</orgName>
								<address>
									<settlement>Cambridge</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="department">Mount Sinai School of Medicine</orgName>
								<orgName type="institution">UNITED STATES</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="institution" key="instit1">Boston University</orgName>
								<orgName type="institution" key="instit2">Columbia University</orgName>
								<orgName type="institution" key="instit3">Duke University</orgName>
								<orgName type="institution" key="instit4">Emory University</orgName>
								<orgName type="institution" key="instit5">Group Health Research Institute</orgName>
								<orgName type="institution" key="instit6">Indiana University</orgName>
								<orgName type="institution" key="instit7">Johns Hopkins University</orgName>
								<address>
									<postCode>P30 AG013846, U01 AG10483, R01 CA129769, R01 MH080295, R01 AG017173, R01 AG025259, R01AG33193, P50 AG008702, R37 AG015473, P30 AG028377, AG05128, AG025688, U01 AG06781, U01 HG004610, U01 HG006375, P30 AG10133, P50 AG005146, R01 AG020688</postCode>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<orgName type="institution">Massachusetts General Hospital</orgName>
								<address>
									<postCode>P50 AG005134</postCode>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<orgName type="department">Mount Sinai School of Medicine</orgName>
								<orgName type="institution" key="instit1">Mayo Clinic</orgName>
								<orgName type="institution" key="instit2">New York University</orgName>
								<address>
									<postCode>P50 AG016574, P50 AG005138, P01 AG002219, P30 AG08051, MO1RR00096, UL1 RR029893, 5R01AG012101, 5R01AG022374, 5R01AG013616, 1RC2AG036502, 1R01AG035137</postCode>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="institution" key="instit1">Northwestern University</orgName>
								<orgName type="institution" key="instit2">Oregon Health &amp; Science University</orgName>
								<orgName type="institution" key="instit3">Rush University</orgName>
								<orgName type="institution" key="instit4">TGen</orgName>
								<orgName type="institution" key="instit5">University of Alabama at Birmingham</orgName>
								<orgName type="institution" key="instit6">University of Arizona</orgName>
								<address>
									<postCode>P30 AG013854, P30 AG008017, R01 AG026916, P30 AG010161, R01 AG019085, R01 AG15819, R01 AG17917, R01 AG30146, R01 NS059873, P50 AG016582, UL1RR02777, R01 AG031581</postCode>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="institution">University of California</orgName>
								<address>
									<postCode>P30 AG010129</postCode>
									<settlement>Davis</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff16">
								<orgName type="institution">University of California</orgName>
								<address>
									<postCode>P50 AG016573, P50 AG016575, P50 AG016576, P50 AG016577</postCode>
									<settlement>Irvine</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff17">
								<orgName type="institution">University of California</orgName>
								<address>
									<postCode>P50 AG016570</postCode>
									<settlement>Los Angeles</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff18">
								<orgName type="institution">University of California</orgName>
								<address>
									<postCode>P50 AG005131</postCode>
									<settlement>San Diego</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff19">
								<orgName type="institution">University of California</orgName>
								<address>
									<postCode>P50 AG023501, P01 AG019724</postCode>
									<settlement>San Francisco</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff20">
								<orgName type="institution" key="instit1">University of Kentucky</orgName>
								<orgName type="institution" key="instit2">University of Michigan</orgName>
								<orgName type="institution" key="instit3">University of Pennsylvania</orgName>
								<orgName type="institution" key="instit4">University of Pittsburgh</orgName>
								<orgName type="institution" key="instit5">University of Southern California</orgName>
								<orgName type="institution" key="instit6">University of Texas Southwestern</orgName>
								<orgName type="institution" key="instit7">University of Miami</orgName>
								<orgName type="institution" key="instit8">University of Washington</orgName>
								<orgName type="institution" key="instit9">Vanderbilt University</orgName>
								<address>
									<postCode>P30 AG028383, AG05144, P50 AG008671, P30 AG010124, P50 AG005133, AG030653, AG041718, P50 AG005142, P30 AG012300, R01 AG027944, AG010491, AG027944, AG021547, AG019757, P50 AG005136, R01 AG019085</postCode>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff21">
								<orgName type="institution">Duke University Medical</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff22">
								<orgName type="department" key="dep1">Hersenstichting Nederland Breinbrekend Werk</orgName>
								<orgName type="department" key="dep2">Institut de Neuropatologia</orgName>
								<orgName type="institution" key="instit1">International Parkinson Fonds</orgName>
								<orgName type="institution" key="instit2">Internationale Stiching Alzheimer Onderzoek)</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff23">
								<orgName type="institution" key="instit1">Servei Anatomia Patologica</orgName>
								<orgName type="institution" key="instit2">Universitat de Barcelona</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-06-16">June 16, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">90EEE1B8EB721F4C4C190D8C19B7D47F</idno>
					<idno type="DOI">10.1371/journal.pmed.1001841</idno>
					<note type="submission">Received: November 7, 2014 Accepted: May 8, 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:09+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>¶ Membership of the Alzheimer's Disease Genetics Consortium, the Genetic and Environmental Risk in AD (GERAD1) Consortium, and the EPIC-InterAct Consortium is provided in S1 Text.</s><s>Data used in the preparation of this article were obtained from GERAD1.</s><s>As such, the investigators within GERAD1 contributed to the design and implementation of GERAD1 and/or provided data but did not participate in the analysis or writing of this report.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Alzheimer disease (AD) prevalence is rising <ref type="bibr" target="#b0">[1]</ref>, further increasing the social and economic burden of this disease <ref type="bibr" target="#b1">[2]</ref>.</s><s>Epidemiological studies have aimed to identify potentially modifiable risk factors that could be targeted in preventive measures to reduce the incidence of AD.</s><s>These include type 2 diabetes (T2D) and glycemic traits <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b3">4]</ref>, hypertension <ref type="bibr" target="#b4">[5]</ref>, obesity <ref type="bibr" target="#b5">[6]</ref>, dyslipidemia <ref type="bibr" target="#b6">[7]</ref>, smoking <ref type="bibr" target="#b7">[8]</ref>, physical inactivity <ref type="bibr" target="#b4">[5]</ref>, depression <ref type="bibr" target="#b8">[9]</ref>, and low educational attainment <ref type="bibr" target="#b4">[5]</ref>.</s><s>It has been reported that approximately one-third of AD cases worldwide may be attributable to these risk factors <ref type="bibr" target="#b8">[9]</ref>.</s><s>However, this suggestion is predicated on these risk factors having causal effects on AD risk, which is currently uncertain <ref type="bibr" target="#b8">[9]</ref>.</s><s>Given the difficulties in implementing large-scale randomized trials of risk factor modification, alternative approaches are required to investigate the causality of associations and to prioritize the targets for which interventions may be most fruitful <ref type="bibr" target="#b9">[10]</ref>.</s></p><p><s>One method for estimating the causal effects of risk factors with known genetic determinants is Mendelian randomization (MR) <ref type="bibr" target="#b10">[11]</ref>.</s><s>The MR approach exploits the fact that genotypes are randomly assorted at meiosis, and are thus independent of conventional confounding factors and the disease process.</s><s>Therefore, genetic variants associated with intermediate traits can be used to provide an unconfounded estimate of the causal association between the intermediate trait and disease outcome, unaffected by reverse causality.</s><s>This is akin to a "genetically randomized trial."</s><s>For example, if body mass index (BMI) is causally associated with AD, genetic variants causing higher BMI should also be associated with higher risk of AD.</s><s>However, if an observed BMI-AD association is not causal but is due to confounding or reverse causation, genetic variants causing higher BMI would not result in higher risk of AD.</s><s>Here, we sought to estimate the causal effects of potentially modifiable risk factors on risk of AD using MR to inform the etiology of AD and the extent to which AD may be preventable by interventions targeting potentially modifiable risk factors.</s></p><p><s>GERAD, to conduct analyses using data from GERAD members.</s><s>The PI and other key personnel must be qualified investigators with appropriate experience and have the support of at least one GERAD collaborator.</s><s>Proposals can be submitted at any time and will be provided to all GERAD members, who will be asked to review and feedback to the GERAD coordinator (Julie Williams) within 2 weeks.</s><s>Where objections or additional information is sought the proposal may be discussed on the next GERAD conference call.</s><s>Further revision or clarification may be requested at this time.</s><s>After all questions are addressed, the GERAD consortium will provide any objections to the coordinator (Julie Williams).</s><s>All objections will be taken into account and acted on appropriately.</s><s>Individual members can opt-out of projects.</s><s>Proposals should not overlap with analyses that are being performed within GERAD, and should be new and novel research ideas.</s><s>In order to access GERAD data, the receiving Institution is required to enter into a data sharing agreement with Cardiff University which binds them to appropriate use and acknowledgement of the data they receive.</s><s>Only parties involved in this agreement can access GERAD data for the purpose specified in the proposal.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Design</head><p><s>We performed MR analyses using single nucleotide polymorphisms (SNPs) with known associations with potentially modifiable AD risk factors.</s><s>We used summary statistics from the International Genomics of Alzheimer's Project (IGAP) <ref type="bibr" target="#b11">[12]</ref>, the largest genome-wide meta-analysis of AD reported to date, and individual genotype data from a large subset of IGAP to estimate the unconfounded association between each risk factor and AD risk.</s><s>S1 Fig illustrates the study design.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SNPs Associated with Alzheimer Disease Risk Factors</head><p><s>We identified SNPs that had genome-wide significant (p &lt; 5 × 10 −8 ) associations with each risk factor using the largest published genome-wide meta-analysis available in individuals of European ancestry.</s><s>We identified 49 SNPs associated with T2D <ref type="bibr" target="#b12">[13]</ref>, 36 with fasting glucose <ref type="bibr" target="#b13">[14]</ref>, and ten with insulin resistance <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b14">15]</ref>.</s><s>We identified 32 SNPs associated with BMI <ref type="bibr" target="#b15">[16]</ref> and 25 associated with systolic blood pressure (SBP) <ref type="bibr" target="#b16">[17]</ref>.</s><s>Given the overlap of SNPs associated with systolic, diastolic, mean arterial, and pulse pressures, we focused on SBP, which had the largest number of associated SNPs <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b17">18]</ref>.</s><s>We identified 74 SNPs associated with total cholesterol, 71 with high-density lipoprotein (HDL)-cholesterol, 58 with low-density lipoprotein (LDL)-cholesterol, and 40 with triglycerides <ref type="bibr" target="#b18">[19]</ref>.</s><s>We identified one SNP associated with smoking initiation (rs6265 in BDNF; r 2 = 0.74 with the BDNF BMI-associated variant), and three associated with smoking quantity in smokers <ref type="bibr" target="#b19">[20]</ref>.</s><s>We identified two SNPs associated with the probability of completing university and one associated with the number of years of education <ref type="bibr" target="#b20">[21]</ref>.</s><s>We show the SNPs and their associations with their relative traits in S1 Table <ref type="table">.</ref></s><s>Where lead SNPs were not available, we selected a suitable proxy (r 2 &gt; 0.8; except for rs4420638, where the best available proxy was rs6857 [r 2 = 0.46]), as detailed in S1 Table <ref type="table">.</ref></s><s>Within each trait, no SNPs were in linkage disequilibrium (LD) (r 2 &lt; 0.01).</s><s>No SNPs have been reported to be associated with physical activity levels or depression at p &lt; 5 × 10 −8 .</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Alzheimer Disease Genetic Data</head><p><s>IGAP is a large two-stage study based upon genome-wide association studies (GWASs) of AD in individuals of European ancestry <ref type="bibr" target="#b11">[12]</ref>.</s><s>In stage 1, IGAP used genotyped and imputed data on 7,055,881 SNPs to meta-analyze four previously published GWAS datasets consisting of 17,008 AD cases and 37,154 controls (full details in S1 Text).</s><s>Further details on the original genetic discovery analyses, including information regarding recruitment and diagnostic assessment as well as analytical approaches to adjust for population structure, are provided in S1 Text or described in detail elsewhere <ref type="bibr" target="#b11">[12]</ref>.</s><s>We extracted individual SNP associations with AD from IGAP's stage 1 results.</s><s>Three SNPs (rs850303 for SBP; rs3177928 for total and LDLcholesterol; rs645040 for triglycerides) were not available (S1 Table <ref type="table">)</ref>, so were excluded from analyses.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mendelian Randomization Analyses</head><p><s>We used estimated SNP-risk factor and SNP-AD associations to calculate estimates of each risk factor-AD association using an inverse-variance weighted combination of estimates from each SNP <ref type="bibr" target="#b21">[22]</ref>.</s><s>For continuous exposures (BMI, fasting glucose, insulin resistance, lipids, and SBP), we scaled MR estimates per standard deviation (SD) difference of the risk factor.</s><s>Effect sizes on log-fasting insulin were used as weights for the insulin-resistance-associated variants.</s><s>SDs were estimated from up to 10,445 (N min = 9,963) middle-aged adults from the UK population-based Fenland study <ref type="bibr" target="#b22">[23]</ref>.</s><s>Causal estimates are thus presented per genetically predicted SD, and a log-linear association with odds of AD is implicit across the range of intermediate risk factor values.</s><s>We scaled smoking quantity per ten cigarettes per day and scaled educational attainment per year of education.</s><s>For binary exposures (T2D, smoking initiation, completing university), MR estimates are odds ratios (ORs) per genetically predicted unit difference in log-odds of having the relevant exposure.</s><s>Overall, we included 302 non-overlapping SNPs.</s><s>To minimize the possibility of pleiotropic associations influencing results, we performed sensitivity analyses excluding SNPs with a more significant association with AD than expected by chance (p &lt; 0.05/302 = 0.00017), which excluded only four variants in total (S1 Table <ref type="table">)</ref>.</s><s>Furthermore, we investigated the association of each variant with the risk factor relative to the magnitude of association with AD risk to further identify variants that appeared to be outliers and were candidates to be pleiotropic.</s><s>As a further sensitivity analysis, for risk factors that showed evidence of a causal association with AD (p &lt; 3.8 × 10 −3 ), we also performed a "leave one out" analysis to further investigate the possibility that the causal association was driven by a single SNP.</s></p><p><s>We also performed MR analyses of risk factors that showed evidence of a causal association with AD (p &lt; 3.8 × 10 −3 ) using individual-level SNP data from studies in the Alzheimer's Disease Genetics Consortium (ADGC) (cases = 10,079; controls = 9,613) <ref type="bibr" target="#b23">[24]</ref> and the Genetic and Environmental Risk in AD (GERAD1) Consortium (cases = 3,146; controls = 1,224) <ref type="bibr" target="#b24">[25]</ref>, which account for 51% of the IGAP effective sample size (see S1 Text for a description of the ADGC and GERAD1 samples).</s><s>We performed logistic regression analyses of the SNP-predicted AD association adjusting for study site, population substructure, age, and sex, again scaled per 1-SD difference in risk factor.</s></p><p><s>We created unweighted genetic scores based on the number of risk alleles for each SNPrisk factor association and investigated the association of these scores with a range of traits in up to 16,554 individuals from the EPIC-InterAct study <ref type="bibr" target="#b25">[26]</ref> to check the assumption that the SNPs used in the MR analyses are not associated with potential confounders of exposure-AD associations.</s><s>We standardized outcomes and included scores in linear regression models adjusted for age, sex, recruitment center, and subcohort status.</s><s>We natural-log-transformed triglyceride levels before standardization.</s><s>We investigated the association of the SBP-associated variants with both SBP and diastolic blood pressure (DBP).</s><s>We did not adjust observed blood pressure values for antihypertensive usage.</s><s>We used logistic regression to determine associations with the probability of being physically active, being a smoker, or taking antihypertensive medications, and included covariates as above.</s><s>The distribution of the SBP risk score in the EPIC-InterAct study <ref type="bibr" target="#b25">[26]</ref> is shown in S2 Fig.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Table <ref type="table" target="#tab_1">1</ref> shows the estimated associations of each genetically predicted risk factor with AD from MR analysis using a large-scale international investigation of the genetic basis of AD risk in 17,008 individuals with AD and 37,154 controls.</s><s>We observed evidence for a causal association between genetically predicted SBP and AD risk.</s><s>A genetically predicted 1-SD (15.4 mm Hg) higher SBP was associated with lower risk of AD (OR [95% CI]: 0.75 [0.62-0.91];</s><s>p = 3.4 × 10 −3 ).</s><s>We examined each of the SBP SNPs to investigate if particular SNPs were driving the association with AD, but observed no obvious outliers (S3 Fig) <ref type="figure">.</ref></s><s>Furthermore, when we performed all 24 permutations of the "leave one out" analysis, all SNP sets showed consistent evidence of causality (OR per SD of SBP [95% CI] ranged from 0.72 [0.59-0.87] to 0.78 [0.64-0.95]).</s><s>Individual SNP associations with AD are shown in S1 Table <ref type="table">.</ref></s><s>We also performed analyses on a subset of the overall sample using individual-level SNP data from ADGC and GERAD1, which showed results similar to those observed using the inverse-variance weighted approach (OR [95% CI]: 0.69 [0.55-0.85];</s><s>p = 2.0 × 10 −3 ; Fig <ref type="figure">1</ref>).</s><s>We saw no evidence of heterogeneity between individual studies (p = 0.33).</s></p><p><s>In the EPIC-InterAct study, the unweighted SBP genetic score was strongly associated with SBP and DBP overall (Fig 2 <ref type="figure">)</ref> and in all age groups (Fig <ref type="figure">3</ref>) (p &lt; 0.015 for SBP; p &lt; 0.002 for DBP).</s><s>We did not observe associations of the SBP score with other potentially confounding variables in the EPIC-InterAct study (Fig <ref type="figure">2</ref>).</s><s>The unweighted SBP genetic score was associated with a higher probability of taking antihypertensive medication (OR [95% CI]: 1.05 [1.03-1.08];</s><s>p = 6.7 × 10 −8 ) but not with the probability of being physically active or being a smoker (Fig <ref type="figure" target="#fig_3">4</ref>).</s><s>Forty-nine percent of the individuals in the highest quartile of the unweighted SBP genetic score reported taking antihypertensive medication compared to 39% in the lowest quartile.</s></p><p><s>We found strong associations between genetically predicted total, LDL-, and HDL-cholesterol and AD (Table <ref type="table" target="#tab_1">1</ref>).</s><s>Each of these SNP sets included rs6857 near APOE, which is strongly associated with AD risk (OR: 3.2; p = 2.5 × 10 −575 ) <ref type="bibr" target="#b11">[12]</ref> (S4 and S5 Figs) and which was a very clear outlier when we compared effect sizes on lipids against effect sizes on AD (S6-S11 Figs).</s><s>Two of these SNP sets also included rs1883025 from ABCA1, which was associated with AD at a significance level beyond that expected by chance (OR: 1.07; p = 1.0 × 10 −4 ) <ref type="bibr" target="#b11">[12]</ref> and which is in a gene previously implicated in association with AD <ref type="bibr" target="#b26">[27]</ref>.</s><s>After sensitivity analyses excluding these potentially pleiotropic SNPs, we saw no evidence for causal associations between lipid fractions and AD risk (Table <ref type="table" target="#tab_1">1</ref>).</s></p><p><s>We found no evidence to support causal associations between BMI and AD (OR per SD of BMI [95% CI]: 0.99 [0.80-1.19];</s><s>p = 0.78), fasting glucose (OR [95% CI]:1.12 [0.97-1.30];</s><s>p = 0.11), insulin resistance (OR [95% CI]: 1.32 [0.89-1.97];</s><s>p = 0.17), or T2D (OR [95% CI]: 1.01 [0.96-1.07];</s><s>p = 0.57) (Table <ref type="table" target="#tab_1">1</ref>).</s><s>S4   <ref type="figure">.</ref></s><s>These SNPs are both in LD (r 2 = 0.58 and r 2 = 0.33, respectively) with a genome-wide significant association signal for AD in CELF1 <ref type="bibr" target="#b11">[12]</ref>.</s><s>After excluding these variants from their respective SNP sets, BMI results were unchanged (Table <ref type="table" target="#tab_1">1</ref>).</s><s>However, for fasting glucose, following the removal of rs11039149 near MADD, there was a suggestion of an association between higher glucose and higher AD risk (OR [95% CI]: 1.19 [1.03-1.37];</s><s>p = 0.02).</s></p><p><s>We found no evidence to support causal associations between smoking initiation and AD (OR [95% CI]: 0.70 [0.37-1.33];</s><s>p = 0.28).</s><s>We did find an association between genetically predicted higher smoking quantity and lower AD (OR per ten cigarettes/day [95% CI]: 0.67 [0.51-0.89];</s><s>p = 6.5 × 10 −3 ).</s><s>We did not have smoking behavior data for IGAP to obtain estimates for the association with AD among smokers and non-smokers.</s><s>The SNP with the strongest association with smoking quantity <ref type="bibr" target="#b19">[20]</ref>   <ref type="table" target="#tab_1">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The potential of risk factor modifications to impact upon AD incidence depends entirely on causal links between the risk factors and AD.</s><s>Using genetic variants associated with risk factors for AD in a very large consortium of well-characterized research participants, we found evidence for an association between genetically inherited higher levels of blood pressure and lower AD risk.</s></p><p><s>Hypertension has been implicated as a risk factor for AD <ref type="bibr" target="#b4">[5]</ref>.</s><s>However, uncertainties remain over the nature of the association, perhaps complicated by misclassification of AD with other forms of dementia, or the age of study participants <ref type="bibr" target="#b27">[28]</ref>.</s><s>While previous studies have suggested that high blood pressure in midlife is associated with higher AD risk <ref type="bibr" target="#b28">[29,</ref><ref type="bibr" target="#b29">30]</ref>, other studies have indicated that high blood pressure in late life may be protective against AD <ref type="bibr" target="#b30">[31,</ref><ref type="bibr" target="#b31">32]</ref>.</s><s>We found that genetically inherited higher SBP levels are associated with lower risk of AD (Table <ref type="table" target="#tab_1">1</ref>).</s><s>Previous studies have suggested that hypotension may indeed be a risk factor for AD, particularly in the elderly <ref type="bibr" target="#b32">[33]</ref>, potentially via resultant cerebral hypoperfusion <ref type="bibr" target="#b33">[34]</ref>.</s><s>The unweighted SBP gene score was associated with higher SBP levels across the adult lifespan (Fig <ref type="figure">3</ref>).</s><s>It should be noted that the SNPs associated with SBP overlap extensively with those associated with DBP <ref type="bibr" target="#b16">[17]</ref> as well as with pulse pressure <ref type="bibr" target="#b17">[18]</ref>, so we were unable to distinguish between individual components of blood pressure.</s><s>A recent meta-analysis of prospective studies suggested that a 10-mm Hg higher SBP was associated with a protective relative risk of 0.95 (95% CI: 0.91-1.00)</s><s>for AD <ref type="bibr" target="#b27">[28]</ref>.</s><s>Scaling our results to a genetically predicted 10-mm Hg difference in SBP would result in an OR of 0.83 (95% CI: 0.73-0.94)</s><s>for AD.</s><s>Clearly, given that blood pressure is a major risk factor for cardiovascular disease <ref type="bibr" target="#b34">[35]</ref>, one would not advocate raising blood pressure as a preventive strategy, yet these findings offer intriguing etiological insight.</s></p><p><s>We also found that genetically predicted higher SBP was associated with a higher probability of being on antihypertensive medication (Fig <ref type="figure" target="#fig_3">4</ref>).</s><s>There is considerable interest in the role of antihypertensives in dementia, and while findings are equivocal <ref type="bibr" target="#b35">[36]</ref>, recent studies have suggested a possible protective effect of antihypertensive therapy on AD risk <ref type="bibr" target="#b36">[37]</ref>, potentially with heterogeneity of effect by therapeutic class <ref type="bibr" target="#b37">[38]</ref>, suggesting that any effect on AD risk may not be entirely attributable to the lowering of blood pressure, but potentially to other mechanisms.</s><s>The unweighted SBP gene score was strongly associated with observed SBP in the EPIC-Inter-Act study, ignoring any SBP-lowering effects of antihypertensive medications.</s><s>Thus, if antihypertensive medications are indeed protective and confound the association between genetically predicted SBP and AD, their effect on AD risk is likely to be independent of their effect on SBP, as the SBP-associated variants have a strong association with SBP regardless of the higher prevalence of treatment with antihypertensive medication.</s><s>While the null association between genetically predicted lipid levels and AD risk reflects the equivocal findings from trials of statins and cognitive decline <ref type="bibr" target="#b38">[39]</ref>, our results suggest the imperative need for further investigation of the possibility that antihypertensive medications may reduce AD risk independently of their effects on blood pressure.</s><s>Future MR analyses stratified by antihypertensive treatments would be desirable to more precisely estimate the magnitude of the causal effect of higher BP on AD risk, but will be difficult to carry out using existing data due to the time-varying nature of antihypertensive treatments across the life course, and the non-availability of data on lifetime medication usage in most studies.</s></p><p><s>We also observed an association between AD and smoking quantity (Table <ref type="table" target="#tab_1">1</ref>).</s><s>Early reports implicated smoking as protective for AD <ref type="bibr" target="#b39">[40]</ref>, potentially via a neuroprotective effect of nicotine <ref type="bibr" target="#b40">[41]</ref>.</s><s>However, this association may be due to differential survival bias <ref type="bibr" target="#b41">[42]</ref>, and a recent meta-analysis of prospective studies implicates smoking as a risk factor for AD, showing current smokers as being at higher risk of AD than never smokers <ref type="bibr" target="#b7">[8]</ref>.</s><s>One smoking-quantityrelated SNP was associated with AD (p = 0.01).</s><s>This SNP is in the gene CHRNA3 from the nicotinic receptor gene cluster CHRNA5-CHRNA3-CHRNB4. Given the putative actions of nicotine, variants in this locus may confer neuroprotective effects by influencing nicotinic receptor function <ref type="bibr" target="#b40">[41,</ref><ref type="bibr" target="#b42">43]</ref>.</s><s>Thus, altered nicotinic receptor function may underlie the MR association between smoking quantity and AD risk.</s><s>The ideal study would perform MR analyses stratified by smoking status <ref type="bibr" target="#b43">[44]</ref>, particularly if sensitivity analyses could exclude variants in nicotinic receptor genes.</s><s>Such analyses would address the causality of smoking as a risk factor, and offer valuable insight into nicotine's role in the etiology of AD <ref type="bibr" target="#b40">[41,</ref><ref type="bibr" target="#b42">43]</ref>.</s><s>Since smoking is a major cause of global disease burden <ref type="bibr" target="#b44">[45]</ref>, increasing knowledge of the role of nicotine in the etiology of AD may prove to be the more actionable insight.</s></p><p><s>Our findings for total, LDL-, and HDL-cholesterol are not consistent with a causal effect of major lipid fractions on AD risk, as previously suggested in a smaller study <ref type="bibr" target="#b45">[46]</ref>.</s><s>Rather, the well-established association of APOE haplotypes with AD risk <ref type="bibr" target="#b46">[47]</ref> implicates APOE itself as a key causal factor in the etiology of AD.</s><s>Indeed a recent GWAS of plasma APOE levels identified only genetic variants in APOE, and not those in other lipid loci, as being associated with APOE levels at genome-wide significance <ref type="bibr" target="#b47">[48]</ref>.</s><s>When we compared the effect sizes for the effects of SNPs on major lipids relative to the magnitude of their association with AD, the APOE variant was a very clear outlier (S6-S11 Figs).</s></p><p><s>We did not find evidence consistent with a causal role for the other potentially modifiable risk factors we evaluated (Table <ref type="table" target="#tab_1">1</ref>).</s><s>In our sensitivity analysis that excluded the potentially pleiotropic variant near MADD, genetically predicted higher fasting glucose was nominally associated with higher AD risk.</s><s>While these results are consistent with the notion that higher blood glucose may be causally related to AD risk <ref type="bibr" target="#b3">[4]</ref>, the borderline significance warrants a cautious interpretation.</s></p><p><s>A limitation of the MR approach is the limited strength of the SNPs to explain variation in the intermediate traits, restricting statistical power.</s><s>This is particularly true when findings are null, where narrow confidence intervals are important to aid robust inference.</s><s>For example, while we saw no evidence to support causal roles for BMI, fasting glucose, or insulin resistance in AD (all p &gt; 0.1), confidence intervals allow for an almost 20% higher AD risk per 1-SD difference in BMI, a 30% higher AD risk per 1-SD difference in fasting glucose, and an almost 100% higher AD risk per 1-SD difference in log-fasting insulin (Table <ref type="table" target="#tab_1">1</ref>).</s><s>Thus, improving the intermediate trait variance explained by the instrumental variables by further genetic discovery efforts will improve the precision of MR analyses.</s><s>Likewise, ever larger AD GWASs will further narrow confidence intervals around MR estimates.</s><s>The association of genetically predicted blood pressure with AD risk remained after Bonferroni correction for the 13 individual SNP sets we tested (0.05/13 = 3.8 × 10 −3 ), although the association of the smoking-associated variants did not.</s><s>However, we consider this a conservative correction, given the correlation between the intermediate risk factors.</s><s>We cannot exclude the possibility that the protective associations of blood pressure with AD arise as a result of differential survival bias, but the consistency of the observations across both prospective and cross-sectional studies of AD makes this less likely (Fig <ref type="figure">1</ref>), as does the absence of similar MR associations for other major vascular risk factors (Table <ref type="table" target="#tab_1">1</ref>).</s></p><p><s>The main data source for this study is the summary statistics from IGAP, the largest genome-wide meta-analysis of AD reported to date <ref type="bibr" target="#b11">[12]</ref>.</s><s>Since all participants in IGAP are of European ancestry, the results of this study are not necessarily valid for other ethnic groups.</s></p><p><s>In conclusion, we found associations between genetically predicted higher SBP and lower AD risk.</s><s>This finding is contrary to the notion that societal interventions to lower blood pressure will reduce the incidence of AD.</s><s>However, since there is a strong association between higher SBP gene scores and exposure to antihypertensive treatments, there is a need to evaluate the possible protective role of some of these substances against AD, independent of their effects on blood pressure.  <ref type="table">.</ref></s><s>SNPs associated with putative Alzheimer disease risk factors.</s><s>SNPs included in each risk score, their associations estimated by the relevant consortium, and their association with AD (IGAP <ref type="bibr" target="#b11">[12]</ref>).</s><s>Proxies are marked by an asterix in the leftmost column.</s><s>The effect allele frequency was based on data from the EPIC-InterAct study <ref type="bibr" target="#b25">[26]</ref>.</s><s>Double asterisks indicate that frequency information was not available in the EPIC-InterAct study, and were obtained from European 1000 Genomes samples.</s><s>(XLSX) S1 Text.</s><s>Supplemental methods, supplemental results, and acknowledgments.</s><s>(DOCX)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Editors' Summary</head><p><s>Background Worldwide, about 44 million people have dementia, a group of brain degeneration disorders characterized by an irreversible decline in memory, communication, and other "cognitive" functions.</s><s>Dementia mainly affects older people, and because people are living longer, experts estimate that more than 135 million people will have dementia by 2050.</s><s>The most common form of dementia, which accounts for 60%-70% of cases, is Alzheimer disease (AD).</s><s>The earliest sign of AD is often increasing forgetfulness.</s><s>As the disease progresses, affected individuals gradually lose the ability to look after themselves, they may become anxious or aggressive, and they may have difficulty recognizing friends and relatives.</s><s>People with late stage disease may lose control of their bladder and of other physical functions.</s><s>At present, there is no cure for AD, although some of its symptoms can be managed with drugs.</s><s>Most people with AD are initially cared for at home by relatives and other caregivers, but many affected individuals end their days in a care home or specialist nursing home.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Why Was This Study Done?</head><p><s>Researchers are interested in identifying risk factors for AD, particularly modifiable risk factors, because if such risk factors exist, it might be possible to limit the predicted increase in future AD cases.</s><s>Epidemiological studies (investigations that examine patterns of disease in populations) have identified several potential risk factors for AD, including hypertension (high blood pressure), obesity, smoking, and dyslipidemia (changes in how the body handles fats).</s><s>However, epidemiological studies cannot prove that a specific risk factor causes AD.</s><s>For example, people with hypertension might share another characteristic that causes both hypertension and AD (confounding) or AD might cause hypertension (reverse causation).</s><s>Information on causality is needed to decide which risk factors to target to help prevent AD.</s><s>Here, the researchers use "Mendelian randomization" to examine whether differences in several epidemiologically identified risk factors for AD have a causal impact on AD risk.</s><s>In Mendelian randomization, causal associations are inferred from the effects of genetic variants (which predict levels of modifiable risk factors) on the outcome of interest.</s><s>Because gene variants are inherited randomly, they are not prone to confounding and are free from reverse causation.</s><s>So, if hypertension actually causes AD, genetic variants that affect hypertension should be associated with an altered risk of AD.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>What Did the Researchers Do and Find?</head><p><s>The researchers identified causal associations between potentially modifiable risk factors and AD risk by analyzing the occurrence of single nucleotide polymorphisms (SNPs, a type of gene variant) known to predict levels of each risk factor, in genetic data from 17,008 individuals with AD and 37,154 cognitively normal elderly controls collected by the International Genomics of Alzheimer's Project.</s><s>They report that genetically predicted higher systolic blood pressure (SBP; the pressure exerted on the inside of large blood vessels when the heart is pumping out blood) was associated with lower AD risk (and with a higher probability of taking antihypertensive medication).</s><s>Predicted smoking quantity was also associated with lower AD risk, but there was no evidence of causal associations between any of the other risk factors investigated and AD risk.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>What Do These Findings Mean?</head><p><s>In contrast to some epidemiological studies, these findings suggest that hypertension is associated with lower AD risk.</s><s>However, because genetically predicted higher SBP was also associated with a higher probability of taking antihypertensive medication, it could be that exposure to such drugs, rather than having hypertension, reduces AD risk.</s><s>Like all Mendelian randomization studies, the reliability of these findings depends on the validity of several assumptions made by the researchers and on the ability of the SNPs used in the analyses to explain variations in exposure to the various risk factors.</s><s>Moreover, because all the participants in the International Genomics of Alzheimer's Project are of European ancestry, these findings may not be valid for other ethnic groups.</s><s>Given that hypertension is a risk factor for cardiovascular disease, the researchers do not advocate raising blood pressure as a measure to prevent AD (neither do they advocate that people smoke more cigarettes to lower AD risk).</s><s>Rather, given the strong association between higher SBP gene scores and the probability of exposure to antihypertensive treatment, they suggest that the possibility that antihypertensive drugs might reduce AD risk independently of their effects on blood pressure should be investigated as a priority.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Additional Information</head><p><s>This list of resources contains links that can be accessed when viewing the PDF on a device or via the online version of the article at http://dx.doi.org/10.1371/journal.pmed.1001841.</s></p><p><s>• The UK National Health Service Choices website provides information (including personal stories) about Alzheimer disease</s></p><p><s>• The UK not-for-profit organization Alzheimer's Society provides information for patients and carers about dementia, including personal experiences of living with Alzheimer disease</s></p><p><s>• The US not-for-profit organization Alzheimer's Association also provides information for patients and carers about dementia and personal stories about dementia • Alzheimer's Disease International is the federation of Alzheimer disease associations around the world; it provides links to individual Alzheimer associations, information about dementia, and links to world Alzheimer reports</s></p><p><s>• MedlinePlus provides links to additional resources about Alzheimer disease (in English and Spanish)</s></p><p><s>• Wikipedia has a page on Mendelian randomization (note: Wikipedia is a free online encyclopedia that anyone can edit; available in several languages)</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>Fig shows the associations with AD of the SNPs included in all genetic analyses compared to those expected by chance.</s><s>Other than rs6857 near APOE, the most significant associations with AD were observed for rs11039149 (p = 3.7 × 10 −6 ) in the fasting glucose SNPs and rs3817334 (p = 9.3 × 10 −5 ) in the BMI SNPs (see S1</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>was nominally associated with AD risk (rs1051730: OR of AD per smoking-quantity-raising allele [95% CI]: 0.96 [0.93-0.99];</s><s>p = 0.01), while the others were not (S12 Fig).</s><s>We saw no association between AD risk and either university completion (OR [95% CI]: 0.95 [0.67-1.34];</s><s>p = 0.75) or years of education (OR [95% CI]: 0.71 [0.48-1.06];</s><s>p = 0.10) (Table</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 1 .Fig 2 .Fig 3 .</head><label>123</label><figDesc><div><p><s>Fig 1.Mendelian randomization estimates of the association of systolic blood pressure with AD in individual ADGC studies and overall in ADGC, GERAD1, and IGAP.</s><s>This figure shows MR estimates for the association of SBP-associated variants with AD in each of the participant studies in ADGC<ref type="bibr" target="#b23">[24]</ref> and in GERAD1<ref type="bibr" target="#b24">[25]</ref> using individual SNP-level data compared to that observed in IGAP<ref type="bibr" target="#b11">[12]</ref> using summary-level data.</s><s>See S1 Text (supplemental results) for individual study name abbreviations.doi:10.1371/journal.pmed.1001841.g001</s></p></div></figDesc><graphic coords="7,36.00,78.01,440.15,459.72" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 4 .</head><label>4</label><figDesc><div><p><s>Fig 4. Associations of the systolic blood pressure genetic score with binary outcomes in the EPIC-InterAct study.</s><s>This figure shows the investigation of pleiotropic associations of the genetic score for SBP with binary outcomes in the EPIC-InterAct study [26].</s><s>The OR per SBP-raising allele is shown.</s><s>doi:10.1371/journal.pmed.1001841.g004</s></p></div></figDesc><graphic coords="9,36.00,78.01,427.41,272.13" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>S1</head><label></label><figDesc><div><p><s>Checklist.</s><s>STROBE checklist.</s><s>(DOCX) S1 Fig. Illustration of the study design.</s><s>(TIF) S2 Fig. Distribution of the systolic blood pressure genetic risk score in the EPIC-InterAct study.</s><s>n = 16,691.</s><s>(TIF) S1 Table</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="8,36.00,78.01,411.08,198.43" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="8,200.01,368.79,368.39,271.90" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table and S5</head><label>and</label><figDesc><div><p><s>Fig)</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Estimated associations of each genetically predicted risk factor with Alzheimer disease.</s></p></div></figDesc><table><row><cell>Trait</cell><cell>Scaling of OR</cell><cell>Number of SNPs</cell><cell cols="2">Overall Results</cell><cell cols="2">Sensitivity Analyses*</cell></row><row><cell></cell><cell></cell><cell></cell><cell>OR (95% CI)</cell><cell>p-Value</cell><cell>OR (95% CI)</cell><cell>p-Value</cell></row><row><cell>BMI</cell><cell>SD (4.81 kg/m 2 )</cell><cell>32</cell><cell>0.99 (0.80−1.19)</cell><cell>0.779</cell><cell>1.00 (0.82−1.22)</cell><cell>0.97</cell></row><row><cell>T2D</cell><cell>unit higher log-odds</cell><cell>49</cell><cell>1.02 (0.97−1.07)</cell><cell>0.535</cell><cell></cell><cell></cell></row><row><cell>Fasting glucose</cell><cell>SD (0.65 mmol/l)</cell><cell>36</cell><cell>1.12 (0.97−1.30)</cell><cell>0.112</cell><cell>1.19 (1.03−1.37)</cell><cell>0.02</cell></row><row><cell>Insulin resistance</cell><cell>SD log-FI (0.60 log-pmol/l)</cell><cell>10</cell><cell>1.32 (0.88−1.98)</cell><cell>0.177</cell><cell></cell><cell></cell></row><row><cell>SBP</cell><cell>SD (15.4 mm Hg)</cell><cell>24</cell><cell>0.75 (0.62−0.91)</cell><cell>3.4 × 10 −3</cell><cell></cell><cell></cell></row><row><cell>Total cholesterol</cell><cell>SD (1.03 mmol/l)</cell><cell>73</cell><cell>1.94 (1.79−2.10)</cell><cell>3.1 × 10 −56</cell><cell>1.04 (0.95−1.13)</cell><cell>0.84</cell></row><row><cell>HDL-cholesterol</cell><cell>SD (0.41 mmol/l)</cell><cell>71</cell><cell>0.75 (0.69−0.82)</cell><cell>1.0 × 10 −11</cell><cell>1.01 (0.93−1.09)</cell><cell>0.87</cell></row><row><cell>LDL-cholesterol</cell><cell>SD (0.91 mmol/l)</cell><cell>57</cell><cell>2.31 (2.12−2.50)</cell><cell>3.0 × 10 −87</cell><cell>1.07 (0.98−1.17)</cell><cell>0.14</cell></row><row><cell>Triglycerides</cell><cell>SD (0.83 mmol/l)</cell><cell>39</cell><cell>0.96 (0.87−1.07)</cell><cell>0.482</cell><cell></cell><cell></cell></row><row><cell>Smoking initiation</cell><cell>unit higher log-odds</cell><cell>1</cell><cell>0.70 (0.37−1.33)</cell><cell>0.278</cell><cell></cell><cell></cell></row><row><cell>Smoking quantity</cell><cell>cigarettes/day</cell><cell>3</cell><cell>0.67 (0.51−0.89)</cell><cell>6.5 × 10 −3</cell><cell></cell><cell></cell></row><row><cell>Completing university</cell><cell>unit higher log-odds</cell><cell>2</cell><cell>0.95 (0.67−1.34)</cell><cell>0.752</cell><cell></cell><cell></cell></row><row><cell>Length of education</cell><cell>year of education</cell><cell>1</cell><cell>0.71 (0.48−1.06)</cell><cell>0.097</cell><cell></cell><cell></cell></row></table><note><p><s>*Sensitivity analyses exclude SNPs where p &lt; 0.00017 (0.05/302 unique SNPs) for AD.</s><s>log-FI, log-fasting insulin.</s><s>doi:10.1371/journal.pmed.1001841.t001</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head></head><label></label><figDesc><div><p><s>• A PLOS Medicine Research Article by Proitsi et al. describes a Mendelian randomization study that looked for a causal association between dyslipidemia and Alzheimer disease</s></p></div></figDesc><table /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS Medicine | DOI:10.1371/journal.pmed.1001841 June 16, 2015</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0" />
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Competing Interests: SDØ has received speaking fees, consultant honoraria and travel support from Janssen-Cilag until April 2011.</s><s>Furthermore, he has received travel support at one occasion in 2010 from Bristol-Myers Squibb.</s><s>EBL reports grants from National Institute on Aging during the conduct of the study, and personal fees from UpToDate outside the submitted work.</s><s>All other authors have nothing to disclose.</s><s><ref type="bibr" target="#b11">[12]</ref> against their estimated associations with total cholesterol from <ref type="bibr" target="#b18">[19]</ref> including the APOE allele.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Abbreviations</head><p><s>(TIF) S7 Fig.</s><s>Estimated associations of SNPs with AD (ln-ORs and 95% CIs) from IGAP <ref type="bibr" target="#b11">[12]</ref> against their estimated associations with total cholesterol from <ref type="bibr" target="#b18">[19]</ref> excluding the APOE allele.</s></p><p><s>(TIF) S8 Fig.</s><s>Estimated associations of SNPs with AD (ln-ORs and 95% CIs) from IGAP <ref type="bibr" target="#b11">[12]</ref> against their estimated associations with HDL-cholesterol from <ref type="bibr" target="#b18">[19]</ref> including the APOE allele.</s></p><p><s>(TIF) S9 Fig.</s><s>Estimated associations of SNPs with AD (ln-ORs and 95% CIs) from IGAP <ref type="bibr" target="#b11">[12]</ref> against their estimated associations with HDL-cholesterol from <ref type="bibr" target="#b18">[19]</ref> excluding the APOE allele.</s><s>(TIF) S10 Fig.</s><s>Estimated associations of SNPs with AD (ln-ORs and 95% CIs) from IGAP <ref type="bibr" target="#b11">[12]</ref> against their estimated associations with LDL-cholesterol from <ref type="bibr" target="#b18">[19]</ref> including the APOE allele.</s><s>(TIF) S11 Fig.</s><s>Estimated associations of SNPs with AD (ln-ORs and 95% CIs) from IGAP <ref type="bibr" target="#b11">[12]</ref> against their estimated associations with LDL-cholesterol from <ref type="bibr" target="#b18">[19]</ref> excluding the APOE allele.</s><s>(TIF) S12 Fig.</s><s>Estimated associations of SNPs with AD (ln-ORs and 95% CIs) from IGAP <ref type="bibr" target="#b11">[12]</ref> against their estimated associations with smoking quantity derived from the Tobacco and Genetics Consortium GWAS <ref type="bibr" target="#b19">[20]</ref>.</s><s>Ã Note that the effect sizes for the effects of SNPs on smoking quantity were estimated in current smokers only, while the associations with AD are not stratified by smoking status.</s><s>(TIF)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Contributions</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The global prevalence of dementia: a systematic review and metaanalysis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Prince</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bryce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Albanese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wimo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ribeiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Ferri</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jalz.2012.11.007</idno>
		<idno type="PMID">23305823</idno>
	</analytic>
	<monogr>
		<title level="j">Alzheimers Dement</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="63" to="75" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers</title>
		<author>
			<persName><forename type="first">C</forename><surname>Reitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mayeux</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bcp.2013.12.024</idno>
		<idno type="PMID">24398425</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem Pharmacol</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="640" to="651" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Type 2 diabetes as a risk factor for Alzheimer&apos;s disease: the confounders, interactions, and neuropathology associated with this relationship</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">T</forename><surname>Vagelatos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Eslick</surname></persName>
		</author>
		<idno type="DOI">10.1093/epirev/mxs012</idno>
		<idno type="PMID">23314404</idno>
	</analytic>
	<monogr>
		<title level="j">Epidemiol Rev</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="152" to="160" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Glucose levels and risk of dementia</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Crane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Hubbard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Nathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zheng</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa1215740</idno>
		<idno type="PMID">23924004</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page" from="540" to="548" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">The projected effect of risk factor reduction on Alzheimer&apos;s disease prevalence</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yaffe</surname></persName>
		</author>
		<idno type="DOI">10.1016/S1474-4422(11)70072-2</idno>
		<idno type="PMID">21775213</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="819" to="828" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Development of a new method for assessing global risk of Alzheimer&apos;s disease for use in population health approaches to prevention</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Anstey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Cherbuin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Herath</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11121-012-0313-2</idno>
		<idno type="PMID">23319292</idno>
	</analytic>
	<monogr>
		<title level="j">Prev Sci</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="411" to="421" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Midlife cardiovascular risk factors and risk of dementia in late life</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Whitmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sidney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Selby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Johnston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yaffe</surname></persName>
		</author>
		<idno type="PMID">15668425</idno>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="277" to="281" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Smoking, dementia and cognitive decline in the elderly, a systematic review</title>
		<author>
			<persName><forename type="first">R</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Poulter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Warner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Beckett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Burch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bulpitt</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2318-8-36</idno>
		<idno type="PMID">19105840</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Geriatr</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">36</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Potential for primary prevention of Alzheimer&apos;s disease: an analysis of population-based data</title>
		<author>
			<persName><forename type="first">S</forename><surname>Norton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yaffe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Brayne</surname></persName>
		</author>
		<idno type="DOI">10.1016/S1474-4422(14)70136-X</idno>
		<idno type="PMID">25030513</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet Neurol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">14</biblScope>
			<biblScope unit="page">70136</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Use of Mendelian randomisation to assess potential benefit of clinical intervention</title>
		<author>
			<persName><forename type="first">S</forename><surname>Burgess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Butterworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Malarstig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Thompson</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.e7325</idno>
		<idno type="PMID">23131671</idno>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">345</biblScope>
			<biblScope unit="page">e7325</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Mendelian randomization&apos;: can genetic epidemiology contribute to understanding environmental determinants of disease?</title>
		<author>
			<persName><forename type="first">Davey</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ebrahim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<idno type="PMID">12689998</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="1" to="22" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Ibrahim-Verbaas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Harold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Naj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sims</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bellenguez</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.2802</idno>
		<idno type="PMID">24162737</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1452" to="1458" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">F</forename><surname>Voight</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Teslovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ferreira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Segre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Steinthorsdottir</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.2383</idno>
		<idno type="PMID">22885922</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="981" to="990" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Lagou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Welch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wheeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Montasser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Luan</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.2385</idno>
		<idno type="PMID">22885924</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="991" to="1005" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independently of obesity</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pasko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Barker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Sharp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Arriola</surname></persName>
		</author>
		<idno type="DOI">10.2337/db14-0319</idno>
		<idno type="PMID">24947364</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="4378" to="4387" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Speliotes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Willer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Berndt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Monda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Thorleifsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">U</forename><surname>Jackson</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.686</idno>
		<idno type="PMID">20935630</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="937" to="948" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Ehret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Munroe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bochud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Johnson</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature10405</idno>
		<idno type="PMID">21909115</idno>
	</analytic>
	<monogr>
		<title level="m">International Consortium for Blood Pressure Genome-Wide Association Studies</title>
				<imprint>
			<date type="published" when="2011">2011</date>
			<biblScope unit="volume">478</biblScope>
			<biblScope unit="page" from="103" to="109" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Wain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Verwoert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>O'reilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Johnson</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.922</idno>
		<idno type="PMID">21909110</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1005" to="1011" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Discovery and refinement of loci associated with lipid levels</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Willer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sengupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Peloso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gustafsson</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.2797</idno>
		<idno type="PMID">24097068</idno>
	</analytic>
	<monogr>
		<title level="j">Global Lipids Genetics Consortium</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1274" to="1283" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Nat Genet</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Genome-wide meta-analyses identify multiple loci associated with smoking behavior</title>
		<author>
			<persName><forename type="first">Genetics</forename><surname>Tobacco</surname></persName>
		</author>
		<author>
			<persName><surname>Consortium</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.571</idno>
		<idno type="PMID">20418890</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="441" to="447" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">GWAS of 126,559 individuals identifies genetic variants associated with educational attainment</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Rietveld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Medland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Derringer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Esko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Martin</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1235488</idno>
		<idno type="PMID">23722424</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">340</biblScope>
			<biblScope unit="page" from="1467" to="1471" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Mendelian randomization analysis with multiple genetic variants using summarized data</title>
		<author>
			<persName><forename type="first">S</forename><surname>Burgess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Butterworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Thompson</surname></persName>
		</author>
		<idno type="DOI">10.1002/gepi.21758</idno>
		<idno type="PMID">24114802</idno>
	</analytic>
	<monogr>
		<title level="j">Genet Epidemiol</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="658" to="665" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Association between birth weight and visceral fat in adults</title>
		<author>
			<persName><forename type="first">Rolfe</forename><surname>Ede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Loos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Druet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stolk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Ekelund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Griffin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename></persName>
		</author>
		<idno type="DOI">10.3945/ajcn.2010.29247</idno>
		<idno type="PMID">20519560</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="347" to="352" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Common variants at MS4A4/ MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Naj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Jun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Beecham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Vardarajan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Buros</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.801</idno>
		<idno type="PMID">21460841</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="436" to="441" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">D</forename><surname>Harold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hollingworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sims</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gerrish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Hamshere</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.440</idno>
		<idno type="PMID">19734902</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1088" to="1093" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Design and cohort description of the InterAct project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC study</title>
		<author>
			<persName><forename type="first">Interact</forename><surname>Consortium</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Langenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sharp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Forouhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Franks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Schulze</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00125-011-2182-9</idno>
		<idno type="PMID">21717116</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="2272" to="2282" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism</title>
		<author>
			<persName><forename type="first">H</forename><surname>Katzov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chalmers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Palmgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Andreasen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Johansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Cairns</surname></persName>
		</author>
		<idno type="PMID">15024730</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Mutat</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="358" to="367" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Power</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Weuve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Gagne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Mcqueen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Viswanathan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Blacker</surname></persName>
		</author>
		<idno type="DOI">10.1097/EDE.0b013e31822708b5</idno>
		<idno type="PMID">21705906</idno>
	</analytic>
	<monogr>
		<title level="j">Epidemiology</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="646" to="659" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Midlife blood pressure and dementia:the Honolulu-Asia aging study</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Launer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Ross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Petrovitch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Masaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Foley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>White</surname></persName>
		</author>
		<idno type="PMID">10794848</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiol Aging</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="49" to="55" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Midlife vascular risk factors and Alzheimer&apos;s disease in later life: longitudinal, population based study</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kivipelto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Helkala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Laakso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hanninen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hallikainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Alhainen</surname></persName>
		</author>
		<idno type="PMID">11408299</idno>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">322</biblScope>
			<biblScope unit="page" from="1447" to="1451" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Low diastolic pressure and risk of dementia in very old people: a longitudinal study</title>
		<author>
			<persName><forename type="first">C</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Winblad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fratiglioni</surname></persName>
		</author>
		<idno type="DOI">10.1159/000236913</idno>
		<idno type="PMID">19752556</idno>
	</analytic>
	<monogr>
		<title level="j">Dement Geriatr Cogn Disord</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="213" to="219" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Dementia and lower blood pressure in Latin America, India, and China: a 10/66 cross-cohort study</title>
		<author>
			<persName><forename type="first">E</forename><surname>Albanese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Lombardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Prince</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="DOI">10.1212/WNL.0b013e31829bfe66</idno>
		<idno type="PMID">23771488</idno>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="228" to="235" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Low blood pressure and dementia in elderly people: the Kungsholmen project</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Viitanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fratiglioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Winblad</surname></persName>
		</author>
		<idno type="PMID">8608286</idno>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">312</biblScope>
			<biblScope unit="page" from="805" to="808" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Cardiovascular risk factors promote brain hypoperfusion leading to cognitive decline and dementia</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>De La Torre</surname></persName>
		</author>
		<idno type="DOI">10.1155/2012/367516</idno>
		<idno type="PMID">23243502</idno>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Psychiatry Neurol</title>
		<imprint>
			<biblScope unit="volume">2012</biblScope>
			<biblScope unit="page">367516</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lewington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Qizilbash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Peto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Collins</surname></persName>
		</author>
		<idno type="PMID">12493255</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">360</biblScope>
			<biblScope unit="page" from="1903" to="1913" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>Prospective Studies Collaboration</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial</title>
		<author>
			<persName><forename type="first">F</forename><surname>Forette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Seux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Staessen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Thijs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Birkenhager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Babarskiene</surname></persName>
		</author>
		<idno type="PMID">9802273</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">352</biblScope>
			<biblScope unit="page" from="1347" to="1351" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Yasar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Yao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Furberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">L</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Mercado</surname></persName>
		</author>
		<idno type="DOI">10.1212/WNL.0b013e3182a35228</idno>
		<idno type="PMID">23911756</idno>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="896" to="903" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">The prevention of dementia with antihypertensive treatment: new evidence from the systolic hypertension in Europe (Syst-Eur) study</title>
		<author>
			<persName><forename type="first">F</forename><surname>Forette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Seux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Staessen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Thijs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Babarskiene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Babeanu</surname></persName>
		</author>
		<idno type="PMID">12374512</idno>
	</analytic>
	<monogr>
		<title level="j">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="2046" to="2052" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial</title>
		<author>
			<persName><forename type="first">J</forename><surname>Shepherd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Blauw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Bollen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Buckley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Cobbe</surname></persName>
		</author>
		<idno type="PMID">12457784</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">360</biblScope>
			<biblScope unit="page" from="1623" to="1630" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Alcohol and tobacco consumption as risk factors for Alzheimer&apos;s disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Graves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Van Duijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Chandra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fratiglioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Heyman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Jorm</surname></persName>
		</author>
		<idno type="PMID">1833354</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="S48" to="S57" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Nicotine inhibits amyloid formation by the beta-peptide</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Salomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Marcinowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Friedland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Zagorski</surname></persName>
		</author>
		<idno type="PMID">8885836</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="13568" to="13578" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Smoking and Alzheimer&apos;s disease: protective effect or differential survival bias?</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Riggs</surname></persName>
		</author>
		<idno type="PMID">8103882</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">342</biblScope>
			<biblScope unit="page" from="793" to="794" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Chronic stress and Alzheimer&apos;s disease-like pathogenesis in a rat model: prevention by nicotine</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Alkadhi</surname></persName>
		</author>
		<idno type="DOI">10.2174/157015911798376307</idno>
		<idno type="PMID">22654719</idno>
	</analytic>
	<monogr>
		<title level="j">Curr Neuropharmacol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="587" to="597" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Freathy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Kazeem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Paternoster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ebrahim</surname></persName>
		</author>
		<idno type="DOI">10.1093/ije/dyr077</idno>
		<idno type="PMID">21593077</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Epidemiol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1617" to="1628" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Flaxman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Danaei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shibuya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Adair-Rohani</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(12)61766-8</idno>
		<idno type="PMID">23245609</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">380</biblScope>
			<biblScope unit="page" from="2224" to="2260" />
			<date type="published" when="2010">2010. 2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Proitsi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Lupton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Velayudhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Newhouse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Fogh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tsolaki</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pmed.1001713</idno>
		<idno type="PMID">25226301</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS Med</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">e1001713</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer&apos;s disease in late onset families</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Corder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Schmechel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">C</forename><surname>Gaskell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Small</surname></persName>
		</author>
		<idno type="PMID">8346443</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">261</biblScope>
			<biblScope unit="page" from="921" to="923" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Identification of a functional apolipoprotein E promoter polymorphism regulating plasma apolipoprotein E concentration</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N</forename><surname>Mannila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mahdessian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Franco-Cereceda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Eggertsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>De Faire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Syvanen</surname></persName>
		</author>
		<idno type="DOI">10.1161/ATVBAHA.112.300353</idno>
		<idno type="PMID">23430611</idno>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1063" to="1069" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
